MOPP (oncology)/Definition: Difference between revisions
Jump to navigation
Jump to search
imported>Howard C. Berkowitz (New page: <noinclude>{{Subpages}}</noinclude> A combination regimen, for cancer chemotherapy, of the antineoplastic agents methotrexate, Oncovin (brand of [[vincristine]...) |
imported>Ro Thorpe mNo edit summary |
||
| Line 1: | Line 1: | ||
<noinclude>{{Subpages}}</noinclude> | <noinclude>{{Subpages}}</noinclude> | ||
A combination regimen, for [[medical oncology|cancer chemotherapy]], of the [[antineoplastic agents]] [[methotrexate]], Oncovin (brand of [[vincristine]]), [[procarbazine]] and [[prednisone]]; generally | A combination regimen, for [[medical oncology|cancer chemotherapy]], of the [[antineoplastic agents]] [[methotrexate]], Oncovin (brand of [[vincristine]]), [[procarbazine]] and [[prednisone]]; generally superseded by newer combinations | ||
Latest revision as of 18:03, 10 November 2010
This article contains just a definition and optionally other subpages (such as a list of related articles), but no metadata. Create the metadata page if you want to expand this into a full article.
MOPP (oncology) [r]: A combination regimen, for cancer chemotherapy, of the antineoplastic agents methotrexate, Oncovin (brand of vincristine), procarbazine and prednisone; generally superseded by newer combinations